LBO — LAS PALMAS MEDICAL CENTER
IRR: 18.6% | MOIC: 2.35x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
18.6%
IRR
2.35x
MOIC
$580.7M
Entry EV
$945.3M
Exit EV
$298.8M
Equity Invested
Sources & Uses
S&UTotal · $580.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $225.5M | 38.8% | |
| Sub Debt | $56.4M | 9.7% | |
| Equity | $298.8M | 51.5% | |
| Enterprise Value | $563.8M | 97.1% | |
| Transaction Fees | $16.9M | 2.9% | |
| Total Uses | $580.7M | 100.0% |
Interpretation
INTAt 2.35x MOIC and 18.6% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $90.0M |
| Exit Ev | $945.3M |
| Net Debt At Exit | $244.0M |
| Equity At Exit | $701.2M |
| Equity Invested | $298.8M |
| Total Value Created | $402.4M |
| Value From Growth | $353.3M |
| Value From Multiple | $28.2M |
| Value From Deleveraging | $37.8M |